You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

Article metrics

Article menu

Download PDFPDF

Late-breaking abstracts
Clinical trials in-progress
809 Phase 2 trial of neoadjuvant and adjuvant PD-1 checkpoint blockade in local-regionally advanced, resectable HNSCC indicates pathological response is associated with high disease-free survival

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 202093011
Dec 20203005
Jan 20212204
Feb 20218406
Mar 202171011
Apr 20216606
May 202126014
Jun 2021004
Jul 2021009
Aug 20210010
Sep 2021007
Oct 202140025
Nov 202148023
Dec 20212602
Jan 20223205
Feb 202218011
Mar 20222008
Apr 20227207
May 20224003
Jun 20223407
Jul 20222201
Aug 20223204
Sep 20225408
Oct 20224403
Nov 20222804
Dec 20223203
Jan 20232005
Feb 20233404
Mar 20234204
Apr 202328010
May 20233804
Jun 20231205
Jul 20232807
Aug 20233204
Sep 20231001
Oct 20235804
Nov 20232603
Dec 20234201
Jan 20243600
Feb 20241800
Mar 20243609
Apr 20242604
May 20244804
Jun 20241601
Jul 20243403
Aug 20242202
Sep 20245005
Oct 20242803
Nov 20242809
Dec 20242207
Jan 20252806
Feb 2025008
Mar 2025005
Apr 2025004
May 2025008
Jun 2025004
Total16960335